subject area of
- Deferiprone in Friedreich ataxia: A 6-Month randomized controlled trial Academic Article
- Deferiprone-related arthropathy of the knee in a thalassemic patient: report of a case and review of the literature Academic Article
- Effect of Age at the Start of Iron Chelation Therapy on Gonadal Function in β-Thalassemia Major Academic Article
- Effects of iron binding agents on Saccharomyces cerevisiae growth and cytochrome P450 content Academic Article
- Fanconi Syndrome Secondary to Deferasirox in Diamond-Blackfan Anemia: Case Series and Recommendations for Early Diagnosis Academic Article
- Inflammation and oxidant-stress in -thalassemia patients treated with iron chelators deferasirox (ICL670) or deferoxamine: an ancillary study of the Novartis CICL670A0107 trial Academic Article
- Iron chelation therapy in patients with low‐ to intermediate‐risk myelodysplastic syndrome: A systematic review and meta‐analysis Academic Article
- Iron overload in myelodysplastic syndromes: A Canadian consensus guideline Academic Article
- Iron promotes cadmium binding to citrate. Academic Article
- Lack of progressive hepatic fibrosis during long-term therapy with deferiprone in subjects with transfusion-dependent beta-thalassemia Academic Article
- Metal-Induced Isomerization Yields an Intracellular Chelator that Disrupts Bacterial Iron Homeostasis Academic Article
- Overall survival in lower IPSS risk MDS by receipt of iron chelation therapy, adjusting for patient-related factors and measuring from time of first red blood cell transfusion dependence: an MDS-CAN analysis Academic Article
- The use of skin Fe levels as a surrogate marker for organ Fe levels, to monitor treatment in cases of iron overload Academic Article
- Thiostrepton Hijacks Pyoverdine Receptors To Inhibit Growth of Pseudomonas aeruginosa Academic Article
- Transcriptional effects of hypoxia on fusiogenic syncytin and its receptor ASCT2 in human cytotrophoblast BeWo cells and in ex vivo perfused placental cotyledons Academic Article